$TRXDW
Stock $trxdw

$trxdw Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-Q Financial Statement

#000143774921025110 Filed on November 03, 2021

Income Statement

Concept	2021 Q4	2021 Q3	2020 Q3
Revenue	$2.476M	$2.571M	$814.0K
YoY Change	123.67%	215.85%	-59.78%
Cost Of Revenue	$2.287M	$3.350M	$1.423M
YoY Change	285.67%	135.42%	-58.71%
Gross Profit	$189.0K	-$779.0K	-$609.0K
YoY Change	-63.23%	27.91%	-57.17%
Gross Profit Margin	7.63%	-30.3%	-74.82%
Selling, General & Admin	$9.155M	$9.108M	$6.598M
YoY Change	41.19%	38.04%	-48.42%
% of Gross Profit	4843.92%
Research & Development	$6.575M	$4.469M	$4.673M
YoY Change	75.33%	-4.37%	-20.58%
% of Gross Profit	3478.84%
Depreciation & Amortization	$3.162M	$3.635M	$3.634M
YoY Change	-15.0%	0.03%	18.37%
% of Gross Profit	1673.02%
Operating Expenses	$15.87M	$16.66M	$14.55M
YoY Change	11.55%	14.47%	-84.91%
Operating Profit	-$15.68M	-$17.44M	-$15.16M
YoY Change	14.36%	15.01%	-84.5%
Interest Expense	$44.00K	$65.00K	$0.00
YoY Change	-129.73%		-100.0%
% of Operating Profit
Other Income/Expense, Net	-$12.00K	$1.401M	$82.00K
YoY Change	-81.54%	1608.54%	-108.27%
Pretax Income	-$15.65M	-$16.04M	-$15.08M
YoY Change	12.43%	6.35%	-84.74%
Income Tax	$229.0K	$32.00K	$2.000K
% Of Pretax Income
Net Earnings	-$15.88M	-$16.07M	-$15.08M
YoY Change	15.15%	6.54%	-84.57%
Net Earnings / Revenue	-641.4%	-625.01%	-1852.83%
Basic Earnings Per Share		-$0.07	-$0.15
Diluted Earnings Per Share	-$67.60K	-$68.57K	-$0.15
COMMON SHARES
Basic Shares Outstanding	234.4M	234.3M	97.54M
Diluted Shares Outstanding			97.54M

Balance Sheet

Concept	2021 Q4	2021 Q3	2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$98.39M	$117.8M	$19.96M
YoY Change	501.3%	489.82%	-9.67%
Cash & Equivalents	$18.13M	$59.78M	$20.00M
Short-Term Investments	$80.26M	$57.97M
Other Short-Term Assets	$957.0K	$627.0K	$5.780M
YoY Change	-67.73%	-89.15%	-34.03%
Inventory	$8.634M	$11.95M	$10.86M
Prepaid Expenses	$3.255M	$2.209M
Receivables	$749.0K	$955.0K	$903.0K
Other Receivables	$1.311M	$1.311M	$0.00
Total Short-Term Assets	$113.3M	$134.8M	$37.50M
YoY Change	233.1%	259.46%	-20.03%
LONG-TERM ASSETS
Property, Plant & Equipment	$10.97M	$9.911M	$8.702M
YoY Change	6.08%	13.89%	60.32%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$37.44M	$30.14M
YoY Change
Other Assets	$1.014M	$348.0K	$1.836M
YoY Change	445.16%	-81.05%	-28.95%
Total Long-Term Assets	$73.18M	$64.95M	$42.64M
YoY Change	65.39%	52.32%	-15.95%
TOTAL ASSETS
Total Short-Term Assets	$113.3M	$134.8M	$37.50M
Total Long-Term Assets	$73.18M	$64.95M	$42.64M
Total Assets	$186.5M	$199.8M	$80.14M
YoY Change	138.28%	149.25%	-17.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.448M	$3.231M	$2.973M
YoY Change	75.47%	8.68%	-12.64%
Accrued Expenses	$5.176M	$4.841M	$7.492M
YoY Change	-7.82%	-35.38%	-7.44%
Deferred Revenue	$543.0K	$678.0K	$818.0K
YoY Change	-31.18%	-17.11%	-7.47%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$0.00	$279.0K
YoY Change	-100.0%	-100.0%
Total Short-Term Liabilities	$9.850M	$9.421M	$11.56M
YoY Change	-4.21%	-18.52%	-7.15%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$2.536M
YoY Change	-100.0%	-100.0%	-83.42%
Other Long-Term Liabilities	$7.377M	$8.837M	$973.0K
YoY Change	1074.68%	808.22%	-38.81%
Total Long-Term Liabilities	$0.00	$0.00	$3.509M
YoY Change	-100.0%	-100.0%	120.69%
TOTAL LIABILITIES
Total Short-Term Liabilities	$9.850M	$9.421M	$11.56M
Total Long-Term Liabilities	$0.00	$0.00	$3.509M
Total Liabilities	$17.23M	$18.26M	$17.98M
YoY Change	3.22%	1.57%	-46.93%
SHAREHOLDERS EQUITY
Retained Earnings	-$785.4M	-$769.5M	-$709.1M
YoY Change	8.64%	8.52%	9.11%
Common Stock	$954.9M	$950.5M	$770.5M
YoY Change	22.18%	23.36%	7.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$169.2M	$181.5M	$62.17M
YoY Change
Total Liabilities & Shareholders Equity	$186.5M	$199.8M	$80.14M
YoY Change	138.28%	149.25%	-17.91%

Cashflow Statement

Concept	2021 Q4	2021 Q3	2020 Q3
OPERATING ACTIVITIES
Net Income	-$15.88M	-$16.07M	-$15.08M
YoY Change	15.15%	6.54%	-84.57%
Depreciation, Depletion And Amortization	$3.162M	$3.635M	$3.634M
YoY Change	-15.0%	0.03%	18.37%
Cash From Operating Activities	-$13.17M	-$9.002M	-$8.774M
YoY Change	3.19%	2.6%	-55.19%
INVESTING ACTIVITIES
Capital Expenditures	-$530.0K	-$138.0K	$0.00
YoY Change			-100.0%
Acquisitions
YoY Change
Other Investing Activities	-$30.07M	-$88.23M	$0.00
YoY Change			-100.0%
Cash From Investing Activities	-$30.60M	-$88.37M	$0.00
YoY Change			-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.564M	33.00K	13.65M
YoY Change	-82.5%	-99.76%	56.35%
NET CHANGE
Cash From Operating Activities	-13.17M	-9.002M	-8.774M
Cash From Investing Activities	-30.60M	-88.37M	0.000
Cash From Financing Activities	1.564M	33.00K	13.65M
Net Change In Cash	-42.21M	-97.34M	4.875M
YoY Change	1002.27%	-2096.7%	-564.29%
FREE CASH FLOW
Cash From Operating Activities	-$13.17M	-$9.002M	-$8.774M
Capital Expenditures	-$530.0K	-$138.0K	$0.00
Free Cash Flow	-$12.64M	-$8.864M	-$8.774M
YoY Change	-0.96%	1.03%	-55.64%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	234389729
CY2021Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	234370083
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	234370083
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	116231072
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	116231072
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000
CY2021Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q3	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	0	USD
CY2020Q3	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	0	USD
	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	0	USD
	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	0	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	0	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	0	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	0	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	0	USD
CY2021Q3	asxc	Property Plant And Equipment Including Purchased Software Impairment Charges PropertyPlantAndEquipmentIncludingPurchasedSoftwareImpairmentCharges	0	USD
CY2020Q3	asxc	Property Plant And Equipment Including Purchased Software Impairment Charges PropertyPlantAndEquipmentIncludingPurchasedSoftwareImpairmentCharges	0	USD
	asxc	Property Plant And Equipment Including Purchased Software Impairment Charges PropertyPlantAndEquipmentIncludingPurchasedSoftwareImpairmentCharges	0	USD
	asxc	Property Plant And Equipment Including Purchased Software Impairment Charges PropertyPlantAndEquipmentIncludingPurchasedSoftwareImpairmentCharges	0	USD
	asxc	Other Income Employer Retention Tax Credit OtherIncomeEmployerRetentionTaxCredit	1300000	USD
	asxc	Period Of Service Sale Arrangement PeriodOfServiceSaleArrangement	P5Y
	asxc	Period Of Service Sale Arrangement At Stated Service Price PeriodOfServiceSaleArrangementAtStatedServicePrice	P4Y
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2021Q3	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	USD
CY2020Q3	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	USD
CY2021Q3	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	0	USD
	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	0	USD
CY2020Q3	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	0	USD
	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	0	USD
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2571000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	814000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2068000	USD
CY2021Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3350000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5756000	USD
CY2021Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2804000	USD
CY2020Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2780000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	8533000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7964000	USD
CY2020Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1423000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	8809000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4573000	USD
CY2021Q3	us-gaap	Gross Profit GrossProfit	-779000	USD
CY2020Q3	us-gaap	Gross Profit GrossProfit	-609000	USD
	us-gaap	Gross Profit GrossProfit	-3053000	USD
	us-gaap	Gross Profit GrossProfit	-2505000	USD
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4469000	USD
CY2020Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4673000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12773000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12867000	USD
CY2021Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3551000	USD
CY2020Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3136000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	10166000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	10291000	USD
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5557000	USD
CY2020Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3462000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13397000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10426000	USD
CY2021Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	278000	USD
CY2020Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	502000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1013000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1770000	USD
CY2021Q3	asxc	Restructuring And Other Charges RestructuringAndOtherCharges	0	USD
CY2020Q3	asxc	Restructuring And Other Charges RestructuringAndOtherCharges	0	USD
	asxc	Restructuring And Other Charges RestructuringAndOtherCharges	0	USD
	asxc	Restructuring And Other Charges RestructuringAndOtherCharges	858000	USD
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	16659000	USD
CY2020Q3	us-gaap	Operating Expenses OperatingExpenses	14553000	USD
	us-gaap	Operating Expenses OperatingExpenses	45882000	USD
	us-gaap	Operating Expenses OperatingExpenses	44176000	USD
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-17438000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-15162000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-48935000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-46681000	USD
CY2021Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2020Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	2847000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-0	USD
CY2020Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-63000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1981000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	206000	USD
CY2021Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	122000	USD
CY2020Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	3000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	253000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	34000	USD
CY2021Q3	us-gaap	Interest Expense InterestExpense	65000	USD
CY2020Q3	us-gaap	Interest Expense InterestExpense	-0	USD
	us-gaap	Interest Expense InterestExpense	77000	USD
	us-gaap	Interest Expense InterestExpense	-0	USD
CY2021Q3	asxc	Other Income Employer Retention Tax Credit OtherIncomeEmployerRetentionTaxCredit	1311000	USD
CY2020Q3	asxc	Other Income Employer Retention Tax Credit OtherIncomeEmployerRetentionTaxCredit	0	USD
	asxc	Other Income Employer Retention Tax Credit OtherIncomeEmployerRetentionTaxCredit	1311000	USD
	asxc	Other Income Employer Retention Tax Credit OtherIncomeEmployerRetentionTaxCredit	0	USD
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	33000	USD
CY2020Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	16000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-54000	USD
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1401000	USD
CY2020Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	82000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2350000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-226000	USD
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16037000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15080000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-46585000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-46907000	USD
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	32000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1386000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-16069000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-15082000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-46581000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-45521000	USD
CY2021Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	-0	USD
CY2020Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	-0	USD
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	-0	USD
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	412000	USD
CY2021Q3	us-gaap	Convertible Preferred Stock Converted To Other Securities ConvertiblePreferredStockConvertedToOtherSecurities	-0	USD
CY2020Q3	us-gaap	Convertible Preferred Stock Converted To Other Securities ConvertiblePreferredStockConvertedToOtherSecurities	-0	USD
	us-gaap	Convertible Preferred Stock Converted To Other Securities ConvertiblePreferredStockConvertedToOtherSecurities	-0	USD
	us-gaap	Convertible Preferred Stock Converted To Other Securities ConvertiblePreferredStockConvertedToOtherSecurities	299000	USD
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-16069000	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-15082000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-46581000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-46232000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-16069000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-15082000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-46581000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-45521000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-931000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	2101000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-2397000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	2191000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-53000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-53000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-17053000	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12981000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-49031000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-43330000	USD
CY2021Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.07
CY2020Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.15
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.21
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.77
CY2021Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	234337000
CY2020Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	97538000
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	224300000
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	59737000
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	59779000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16363000	USD
CY2021Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	57972000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	0	USD
CY2021Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	955000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1115000	USD
CY2021Q3	us-gaap	Inventory Net InventoryNet	11954000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	10034000	USD
CY2021Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2209000	USD
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3535000	USD
CY2021Q3	asxc	Employer Retention Tax Credit Receivable EmployerRetentionTaxCreditReceivable	1311000	USD
CY2020Q4	asxc	Employer Retention Tax Credit Receivable EmployerRetentionTaxCreditReceivable	0	USD
CY2021Q3	us-gaap	Other Assets Current OtherAssetsCurrent	627000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	2966000	USD
CY2021Q3	us-gaap	Assets Current AssetsCurrent	134807000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	34013000	USD
CY2021Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1153000	USD
CY2020Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1166000	USD
CY2021Q3	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	30142000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	0	USD
CY2021Q3	us-gaap	Inventory Noncurrent InventoryNoncurrent	5963000	USD
CY2020Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	8813000	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9911000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10342000	USD
CY2021Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	287000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	307000	USD
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4328000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1164000	USD
CY2021Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	348000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	186000	USD
CY2021Q3	us-gaap	Assets Assets	199759000	USD
CY2020Q4	us-gaap	Assets Assets	78258000	USD
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	3231000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1965000	USD
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4841000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5615000	USD
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	671000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	686000	USD
CY2021Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	678000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	789000	USD
CY2021Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1228000	USD
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	9421000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10283000	USD
CY2021Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	4949000	USD
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	3936000	USD
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3888000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	628000	USD
CY2021Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1587000	USD
CY2021Q3	asxc	Warrant Liability WarrantLiability	0	USD
CY2020Q4	asxc	Warrant Liability WarrantLiability	255000	USD
CY2021Q3	us-gaap	Liabilities Liabilities	18258000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	16689000	USD
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	234000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	116000	USD
CY2021Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	950242000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	781397000	USD
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-769493000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-722912000	USD
CY2021Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	518000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2968000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	181501000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	61569000	USD
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	199759000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	78258000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	61569000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1786000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	129322000	USD
CY2021Q1	asxc	Stock Issued During Period Value Stock Options And Warrants Exercised StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised	32732000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	1000	USD
CY2021Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	214000	USD
CY2021Q1	us-gaap	Treasury Stock Retired Cost Method Amount TreasuryStockRetiredCostMethodAmount	-0	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1938000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-17340000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	205918000	USD
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1842000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	992000	USD
CY2021Q2	asxc	Stock Issued During Period Value Stock Options And Warrants Exercised StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised	337000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	1000	USD
CY2021Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	829000	USD
CY2021Q2	us-gaap	Treasury Stock Retired Cost Method Amount TreasuryStockRetiredCostMethodAmount	-0	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	472000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-13172000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	195561000	USD
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2961000	USD
CY2021Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	47000	USD
CY2021Q3	asxc	Stock Issued During Period Value Stock Options And Warrants Exercised StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised	2000	USD
CY2021Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2021Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	17000	USD
CY2021Q3	us-gaap	Treasury Stock Retired Cost Method Amount TreasuryStockRetiredCostMethodAmount	-0	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-984000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-16069000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	181501000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	55535000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1923000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	11212000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	0	USD
CY2020Q1	asxc	Stock Issued During Period Value Exchange Of Shares For Warrants StockIssuedDuringPeriodValueExchangeOfSharesForWarrants	2470000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2020Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	33000	USD
CY2020Q1	us-gaap	Treasury Stock Retired Cost Method Amount TreasuryStockRetiredCostMethodAmount	-0	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-872000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-16598000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	67162000	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1933000	USD
CY2020Q2	asxc	Stock Issued During Period Value Stock Options And Warrants Exercised StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised	3340000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	0	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	962000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-13840000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	59557000	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1944000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2020Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	13649000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2101000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-15082000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	62169000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-46581000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-45521000	USD
	us-gaap	Depreciation Depreciation	2416000	USD
	us-gaap	Depreciation Depreciation	2015000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	8533000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7964000	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-65000	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-0	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	6589000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	5800000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	2847000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-0	USD
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-4000	USD
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-1386000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	377000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1981000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	206000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1013000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1770000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-113000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	252000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1941000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4410000	USD
	asxc	Increase Decrease In Operating Lease Right Of Use Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets	3174000	USD
	asxc	Increase Decrease In Operating Lease Right Of Use Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets	1045000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-1220000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-1269000	USD
	asxc	Increase Decrease In Tax Credit Receivable IncreaseDecreaseInTaxCreditReceivable	1311000	USD
	asxc	Increase Decrease In Tax Credit Receivable IncreaseDecreaseInTaxCreditReceivable	-0	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-2098000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-2009000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1376000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-706000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-588000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1772000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-81000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-56000	USD
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	3259000	USD
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	-0	USD
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	74000	USD
	asxc	Proceeds From Stock Options And Warrants Exercised ProceedsFromStockOptionsAndWarrantsExercised	30838000	USD
	asxc	Proceeds From Stock Options And Warrants Exercised ProceedsFromStockOptionsAndWarrantsExercised	3340000	USD
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	1115000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	0	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-910000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-27487000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-33910000	USD
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	88232000	USD
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	-0	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	838000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-89070000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3000	USD
	asxc	Proceeds From Issuance Of Equity Net ProceedsFromIssuanceOfEquityNet	0	USD
	asxc	Proceeds From Issuance Of Equity Net ProceedsFromIssuanceOfEquityNet	13525000	USD
	asxc	Proceeds From Issuance Of Common Stock Net ProceedsFromIssuanceOfCommonStockNet	130361000	USD
	asxc	Proceeds From Issuance Of Common Stock Net ProceedsFromIssuanceOfCommonStockNet	24861000	USD
	asxc	Proceeds From Issuance Of Debt And Warrants Net Of Issuance Costs ProceedsFromIssuanceOfDebtAndWarrantsNetOfIssuanceCosts	0	USD
	asxc	Proceeds From Issuance Of Debt And Warrants Net Of Issuance Costs ProceedsFromIssuanceOfDebtAndWarrantsNetOfIssuanceCosts	2815000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1058000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	33000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	160141000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	44434000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-181000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	30000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	43403000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	10551000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17529000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10567000	USD
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	60932000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21118000	USD
	asxc	Transfer Of Inventory To Property And Equipment TransferOfInventoryToPropertyAndEquipment	2156000	USD
	asxc	Transfer Of Inventory To Property And Equipment TransferOfInventoryToPropertyAndEquipment	5839000	USD
	asxc	Reclassification Of Warrant Liability To Common Stock And Additional Paid In Capital ReclassificationOfWarrantLiabilityToCommonStockAndAdditionalPaidInCapital	2236000	USD
	asxc	Reclassification Of Warrant Liability To Common Stock And Additional Paid In Capital ReclassificationOfWarrantLiabilityToCommonStockAndAdditionalPaidInCapital	0	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3857000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
	us-gaap	Stock Issued1 StockIssued1	0	USD
	us-gaap	Stock Issued1 StockIssued1	2470000	USD
	asxc	Transfer Of In Process Research And Development To Intellectual Property TransferOfInProcessResearchAndDevelopmentToIntellectualProperty	0	USD
	asxc	Transfer Of In Process Research And Development To Intellectual Property TransferOfInProcessResearchAndDevelopmentToIntellectualProperty	2425000	USD
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	USD
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	79000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	0	USD
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-769500000	USD
CY2021Q3	asxc	Working Capital WorkingCapital	125400000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	30600000	USD
CY2021Q3	asxc	Cash Cash Equivalents Shortterm And Longterm Investments Excluding Restricted Cash CashCashEquivalentsShorttermAndLongtermInvestmentsExcludingRestrictedCash	147900000	USD
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Use of Estimates</b></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant items subject to such estimates and assumptions include impairment considerations for long- term intangible assets, fair value estimates related to contingent consideration, warrant liabilities, stock compensation expense, revenue recognition, accounts receivable reserves, short-term and long-term investments, excess and obsolete inventory reserves, inventory classification between current and non-current, measurement of lease liabilities and corresponding right-of-use (“ROU”) assets, and deferred tax asset valuation allowances.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The COVID-<em style="font: inherit;">19</em> pandemic has caused significant social and economic restrictions that have been imposed in the United States and abroad, which has resulted in significant volatility in the global economy and led to reduced economic activity. In the preparation of these financial statements and related disclosures, the Company has assessed the impact that COVID-<em style="font: inherit;">19</em> has had on its estimates, assumptions, forecasts, and accounting policies. The Company continues to monitor closely the COVID-<em style="font: inherit;">19</em> pandemic impact on its estimates, assumptions and forecasts used in the preparation of its financial statements. As the COVID-<em style="font: inherit;">19</em> situation is unprecedented and ever evolving, future events and effects related to COVID-<em style="font: inherit;">19</em> cannot be determined with precision, and actual results could significantly differ from estimates or forecasts.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p>
CY2021Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1200000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1200000	USD
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Concentrations and Credit Risk</b></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company’s principal financial instruments subject to potential concentration of credit risk are cash and cash equivalents, and investments, including amounts held in money market funds, commercial paper, and corporate bonds. The Company places cash deposits with a federally insured financial institution. The Company maintains its cash at banks and financial institutions it considers to be of high credit quality; however, the Company’s domestic cash deposits <em style="font: inherit;"> may </em>at times exceed the Federal Deposit Insurance Corporation’s insured limit. Balances in excess of federally insured limitations <em style="font: inherit;"> may </em><em style="font: inherit;">not</em> be insured. The Company has <em style="font: inherit;">not</em> experienced losses on these accounts, and management believes that the Company is <em style="font: inherit;">not</em> exposed to significant risks on such accounts. Investments are stated at their estimated fair values, based on quoted market prices for the same or similar instruments. The counterparties to the agreements relating to the Company’s investments consist of various major corporations, financial institutions, and government agencies of high credit standing.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company’s accounts receivable are derived from sales and leases to customers located throughout the world. The Company evaluates its customers’ financial condition and, generally, requires <em style="font: inherit;">no</em> collateral from its customers. The Company provided reserves for potential credit losses and recorded <em style="font: inherit;">no</em> bad debt charges during the <em style="font: inherit;">three</em> and <em style="font: inherit;">nine</em> months ended <em style="font: inherit;"> September 30, 2021 </em>and <em style="font: inherit;">2020.</em> The Company had <span style="-sec-ix-hidden:c78032151">four</span> customers who constituted 58% of the Company’s net accounts receivable as of <em style="font: inherit;"> September 30, 2021. </em>The Company had <span style="-sec-ix-hidden:c78032153">seven</span> customers who constituted 68% of the Company’s net accounts receivable at <em style="font: inherit;"> December </em><em style="font: inherit;">31,</em> <em style="font: inherit;">2020.</em> The Company had <span style="-sec-ix-hidden:c78032157">one</span> customer who accounted for 61% of revenue in the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> September 30, 2021 </em>and <span style="-sec-ix-hidden:c78032160">nine</span> customers who accounted for 57% of revenue in the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> September 30, 2020. </em>The Company had <span style="-sec-ix-hidden:c78032163">two</span> customers who accounted for 50% of revenue in the <em style="font: inherit;">nine</em> months ended <em style="font: inherit;"> September 30, 2021 </em>and <span style="-sec-ix-hidden:c78032166">nine</span> customers who accounted for 58% of revenue in the <em style="font: inherit;">nine</em> months ended <em style="font: inherit;"> September 30, 2020.</em></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p>
CY2021Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1700000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1800000	USD
CY2021Q3	asxc	Other Income Employer Retention Tax Credit OtherIncomeEmployerRetentionTaxCredit	1300000	USD
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2571000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	814000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5756000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2068000	USD
CY2021Q3	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	300000	USD
CY2020Q3	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	200000	USD
	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	900000	USD
	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	400000	USD
CY2021Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	2700000	USD
CY2020Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	3100000	USD
CY2021Q3	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	100000	USD
CY2020Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	100000	USD
CY2021Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	100000	USD
CY2020Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	100000	USD
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	500000	USD
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	500000	USD
CY2021Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	2700000	USD
CY2021Q3	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	300000	USD
CY2020Q3	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	200000	USD
	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	900000	USD
	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	400000	USD
CY2021Q3	us-gaap	Inventory Write Down InventoryWriteDown	100000	USD
CY2020Q3	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
	us-gaap	Inventory Write Down InventoryWriteDown	400000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2021Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3000000.0	USD
CY2020Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1900000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6600000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5800000	USD
CY2021Q3	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	59779000	USD
CY2021Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1153000	USD
CY2021Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	57972000	USD
CY2021Q3	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	30142000	USD
CY2021Q3	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	149046000	USD
CY2021Q3	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	4949000	USD
CY2021Q3	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	4949000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	16363000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1166000	USD
CY2020Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	17529000	USD
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	3936000	USD
CY2020Q4	asxc	Warrant Liability WarrantLiability	255000	USD
CY2020Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	4191000	USD
CY2021Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	300000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1000000.0	USD
CY2020Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	500000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1800000	USD
CY2017Q2	asxc	Number Of Units Sold NumberOfUnitsSold	24900000
CY2017Q2	asxc	Number Of Shares In Each Unit NumberOfSharesInEachUnit	0.077
CY2017Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1.00
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	2000000.0	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	200000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	2000000.0	USD
CY2021Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
CY2020Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-100000	USD
CY2021Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	11154000	USD
CY2021Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	88167000	USD
CY2021Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2021Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	53000	USD
CY2021Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	88114000	USD
CY2021Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	57972000	USD
CY2021Q3	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	30142000	USD
CY2021Q3	us-gaap	Available For Sale Securities Debt Maturities Remainder Of Fiscal Year Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis	57997000	USD
CY2021Q3	us-gaap	Available For Sale Securities Debt Maturities Remainder Of Fiscal Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue	57972000	USD
CY2021Q3	asxc	Debt Securities Availableforsale Amortized Cost Maturity Next One To Two Years DebtSecuritiesAvailableforsaleAmortizedCostMaturityNextOneToTwoYears	30170000	USD
CY2021Q3	asxc	Debt Securities Availableforsale Fair Value Maturity Next One To Two Years DebtSecuritiesAvailableforsaleFairValueMaturityNextOneToTwoYears	30142000	USD
CY2021Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	88167000	USD
CY2021Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	88114000	USD
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	10749000	USD
CY2021Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	6763000	USD
CY2020Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	8098000	USD
CY2021Q3	asxc	Inventory Current And Noncurrent Net InventoryCurrentAndNoncurrentNet	17917000	USD
CY2020Q4	asxc	Inventory Current And Noncurrent Net InventoryCurrentAndNoncurrentNet	18847000	USD
CY2021Q3	us-gaap	Inventory Net InventoryNet	11954000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	10034000	USD
CY2021Q3	us-gaap	Inventory Noncurrent InventoryNoncurrent	5963000	USD
CY2020Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	8813000	USD
CY2021Q3	asxc	Inventory Current And Noncurrent Net InventoryCurrentAndNoncurrentNet	17917000	USD
CY2020Q4	asxc	Inventory Current And Noncurrent Net InventoryCurrentAndNoncurrentNet	18847000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	69238000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	57399000	USD
CY2021Q3	asxc	Finite Lived Intangible Assets Foreign Currency Translation Impact FiniteLivedIntangibleAssetsForeignCurrencyTranslationImpact	981000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	12820000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	69238000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	51902000	USD
CY2020Q4	asxc	Finite Lived Intangible Assets Foreign Currency Translation Impact FiniteLivedIntangibleAssetsForeignCurrencyTranslationImpact	4931000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	22267000	USD
CY2021Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.002	pure
CY2020Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.030	pure
CY2021Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0.0	USD
CY2020Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0.0	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0.0	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1400000	USD
CY2021Q3	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	30000.00	USD
CY2020Q3	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0.0	USD
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0.00	USD
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	40000.00	USD
CY2021Q3	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	0	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	271000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	983000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	728000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	635000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	635000	USD
CY2020	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	400000	USD
CY2020	us-gaap	Convertible Preferred Stock Converted To Other Securities ConvertiblePreferredStockConvertedToOtherSecurities	300000	USD
	asxc	Stock Issued During Period Shares Warrants Exercised StockIssuedDuringPeriodSharesWarrantsExercised	45317101
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	30600000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	6256000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9994096
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	53699803
CY2021Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.078	pure
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.082	pure
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4300000	USD
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	4600000	USD
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	700000	USD
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3900000	USD
CY2021Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	400000	USD
CY2020Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	500000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	1300000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	1500000	USD
CY2021Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y6M
CY2021Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	300000	USD
CY2020Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	400000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	800000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	1100000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1697000	USD
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	4559000	USD
CY2021Q3	asxc	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	3004000	USD

Files In Submission

Name	View Source	Status
0001437749-21-025110-index-headers.html	Edgar Link	pending
0001437749-21-025110-index.html	Edgar Link	pending
0001437749-21-025110.txt	Edgar Link	pending
0001437749-21-025110-xbrl.zip	Edgar Link	pending
asxc-20210930.xsd	Edgar Link	pending
asxc-20210930_cal.xml	Edgar Link	unprocessable
asxc-20210930_def.xml	Edgar Link	unprocessable
asxc-20210930_lab.xml	Edgar Link	unprocessable
asxc-20210930_pre.xml	Edgar Link	unprocessable
ex_299406.htm	Edgar Link	pending
ex_299407.htm	Edgar Link	pending
ex_299408.htm	Edgar Link	pending
ex_299409.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
transe20210930_10q.htm	Edgar Link	pending
transe20210930_10q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TRXDW
Stock $trxdw

2021 Q4 Form 10-Q Financial Statement

#000143774921025110 Filed on November 03, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TRXDW Stock $trxdw

2021 Q4 Form 10-Q Financial Statement

#000143774921025110 Filed on November 03, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TRXDW
Stock $trxdw